| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 41.4× | −1.7× | |
| Price / Book | 7.3× | 2.0× | |
| Price / Sales | 12.9× | 3.9× | |
| Price / Free cash flow | 63.4× | −1.6× | |
| EV / EBITDA | 38.2× | −1.2× | |
| Earnings yield | 2.4% | −14.6% | |
| Free cash flow yield | 1.6% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,247.60 | −0.75% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $252.11 | −1.35% | $607.56B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.21 | −0.77% | $500.47B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $402.05 | +0.15% | $360.88B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.73 | −0.84% | $357.07B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.19 | −0.29% | $277.84B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.01 | −0.24% | $255.91B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $677.27 | −1.84% | $250.42B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $427.11 | −1.24% | $230.91B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.59 | −1.02% | $191.68B | 22.8× | 37.5% | +32.0% |
